MAM
McCarthy Asset Management Portfolio holdings
AUM
$147M
This Quarter Return
+8.2%
1 Year Return
+8.48%
3 Year Return
+38.27%
5 Year Return
–
10 Year Return
–
AUM
$145M
AUM Growth
+$145M
(+9.3%)
Cap. Flow
+$2.18M
Cap. Flow
% of AUM
1.5%
Top 10 Holdings %
Top 10 Hldgs %
78.42%
Holding
371
New
21
Increased
76
Reduced
35
Closed
38
Top Buys
Top Sells
| 1 |
ZIXI
Zix Corporation
ZIXI
|
$106K |
| 2 |
Gilead Sciences
GILD
|
$103K |
| 3 |
Trade Desk
TTD
|
$70K |
| 4 |
Wells Fargo
WFC
|
$50.3K |
| 5 |
Marvell Technology
MRVL
|
$43.8K |
Sector Composition
| 1 | Healthcare | 8.56% |
| 2 | Technology | 6.12% |
| 3 | Financials | 3.31% |
| 4 | Consumer Discretionary | 3.02% |
| 5 | Communication Services | 2.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pfizer
PFE
$141B
| $123K | 0.08% |
2,089
+3
| +0.1% | +$177 |
|
52
Schwab US Large-Cap Value ETF
SCHV
$13.2B
| $117K | 0.08% |
1,596
+6
| +0.4% | +$440 |
|
53
Ball Corp
BALL
$14.3B
| $113K | 0.08% |
1,172
| – | – |
|
54
JPMorgan Chase
JPM
$829B
| $112K | 0.08% |
708
| – | – |
|
55
Northrop Grumman
NOC
$84.5B
| $111K | 0.08% |
286
+1
| +0.4% | +$388 |
|
56
Zoom
ZM
$24.4B
| $109K | 0.08% |
591
| – | – |
|
57
UGI
UGI
$7.44B
| $103K | 0.07% |
2,250
| – | – |
|
58
CVS Health
CVS
$92.8B
| $99K | 0.07% |
955
-9
| -0.9% | -$933 |
|
59
Idexx Laboratories
IDXX
$51.8B
| $99K | 0.07% |
150
-20
| -12% | -$13.2K |
|
60
Vanguard Mid-Cap ETF
VO
$87.5B
| $97K | 0.07% |
381
-124
| -25% | -$31.6K |
|
61
Schwab Fundamental US Large Company Index ETF
FNDX
$19.8B
| $88K | 0.06% |
1,507
+8
| +0.5% | +$467 |
|
62
AbbVie
ABBV
$372B
| $87K | 0.06% |
642
| – | – |
|
63
Intel
INTC
$107B
| $86K | 0.06% |
1,677
+3
| +0.2% | +$154 |
|
64
GE Aerospace
GE
$292B
| $84K | 0.06% |
891
| – | – |
|
65
Mettler-Toledo International
MTD
$26.8B
| $80K | 0.06% |
47
-17
| -27% | -$28.9K |
|
66
iShares Silver Trust
SLV
$19.6B
| $78K | 0.05% |
3,613
| – | – |
|
67
General Motors
GM
$55.8B
| $71K | 0.05% |
1,211
| – | – |
|
68
Lennar Class A
LEN
$34.5B
| $70K | 0.05% |
600
-17
| -3% | -$1.98K |
|
69
Okta
OKTA
$16.4B
| $67K | 0.05% |
300
| – | – |
|
70
SPDR S&P Biotech ETF
XBI
$5.07B
| $67K | 0.05% |
597
| – | – |
|
71
Abbott
ABT
$231B
| $64K | 0.04% |
454
| – | – |
|
72
Procter & Gamble
PG
$368B
| $64K | 0.04% |
393
| – | – |
|
73
Bank of America
BAC
$376B
| $63K | 0.04% |
1,419
| – | – |
|
74
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$710M
| $62K | 0.04% |
194
+1
| +0.5% | +$320 |
|
75
Philip Morris
PM
$260B
| $56K | 0.04% |
586
| – | – |
|